UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Randomized Phase 2 Trial To Evaluate the Clinical Efficacy of Two High-Dosage Tigecycline Regimens versus Imipenem-Cilastatin for Treatment of Hospital-Acquired Pneumonia

Antimicrobial Agents and Chemotherapy, 2013-04, Vol.57 (4), p.1756-1762

2013

Volltextzugriff (PDF)

Omadacycline vs moxifloxacin in adults with community-acquired bacterial pneumonia

International journal of infectious diseases, 2021-03, Vol.104, p.501-509

2021

Volltextzugriff (PDF)

Omadacycline for Community-Acquired Bacterial Pneumonia

The New England journal of medicine, 2019-02, Vol.380 (6), p.517-527

2019

Volltextzugriff (PDF)

Clinical response and mortality in tigecycline complicated intra-abdominal infection and complicated skin and soft-tissue infection trials

International journal of antimicrobial agents, 2015-09, Vol.46 (3), p.346-350

2015

Volltextzugriff (PDF)

Once-daily oral omadacycline versus twice-daily oral linezolid for acute bacterial skin and skin structure infections (OASIS-2): a phase 3, double-blind, multicentre, randomised, controlled, non-inferiority trial

The Lancet infectious diseases, 2019-10, Vol.19 (10), p.1080-1090

2019

Volltextzugriff (PDF)

Cefepime–Taniborbactam in Complicated Urinary Tract Infection

The New England journal of medicine, 2024-02, Vol.390 (7), p.611-622

2024

Volltextzugriff (PDF)

Safety and efficacy of omadacycline by BMI categories and diabetes history in two Phase III randomized studies of patients with acute bacterial skin and skin structure infections

Journal of antimicrobial chemotherapy, 2021-04, Vol.76 (5), p.1315-1322

2021

Volltextzugriff (PDF)

An Integrated Safety Summary of Omadacycline, a Novel Aminomethylcycline Antibiotic

Clinical infectious diseases, 2019-08, Vol.69 (Supplement_1), p.S40-S47

2019

Volltextzugriff (PDF)

Tigecycline Does Not Prolong Corrected QT Intervals in Healthy Subjects

Antimicrobial Agents and Chemotherapy, 2013-04, Vol.57 (4), p.1895-1901

2013

Volltextzugriff (PDF)

Omadacycline for Acute Bacterial Skin and Skin Structure Infections

Clinical infectious diseases, 2019-08, Vol.69 (Supplement_1), p.S23-S32

2019

Volltextzugriff (PDF)

Patient outcomes by baseline pathogen resistance phenotype and genotype in CERTAIN-1, a Phase 3 study of cefepime-taniborbactam versus meropenem in adults with complicated urinary tract infection

Antimicrobial agents and chemotherapy, 2024-07, Vol.68 (7), p.e0023624

2024

Volltextzugriff (PDF)

All-cause mortality imbalance in the tigecycline phase 3 and 4 clinical trials

International journal of antimicrobial agents, 2013-05, Vol.41 (5), p.463-467

2013

Volltextzugriff (PDF)

Early Clinical Response in Community-acquired Bacterial Pneumonia: From Clinical Endpoint to Clinical Practice

Clinical infectious diseases, 2019-08, Vol.69 (Supplement_1), p.S33-S39

2019

Volltextzugriff (PDF)

Distribution of 13-Valent Pneumococcal Conjugate Vaccine Streptococcus pneumoniae Serotypes in US Adults Aged ≥50 Years With Community-Acquired Pneumonia

The Journal of infectious diseases, 2013-12, Vol.208 (11), p.1813-1820

2013

Volltextzugriff (PDF)

The Effect of Verapamil, a P-gp Inhibitor, on the Pharmacokinetics, Safety, and Tolerability of Omadacycline in Healthy Adults: A Phase I, Open-Label, Single-Sequence Study

European journal of drug metabolism and pharmacokinetics, 2021-01, Vol.46 (1), p.85-92

2021

Volltextzugriff (PDF)

Efficacy and Safety of Omadacycline Versus Linezolid in Acute Bacterial Skin and Skin Structure Infections in Persons Who Inject Drugs

Infectious diseases and therapy, 2022-02, Vol.11 (1), p.517-531

2022

Volltextzugriff (PDF)

Safety and efficacy of omadacycline for treatment of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections in patients with mild-to-moderate renal impairment

International journal of antimicrobial agents, 2021-02, Vol.57 (2), p.106263-106263, Article 106263

2021

Volltextzugriff (PDF)

Endemic babesiosis in another eastern state: New Jersey

Emerging infectious diseases, 2003-02, Vol.9 (2), p.184-188

2003

Volltextzugriff (PDF)

Pancreatitis in tigecycline Phase 3 and 4 clinical studies

Journal of antimicrobial chemotherapy, 2014-03, Vol.69 (3), p.773-778

2014

Volltextzugriff (PDF)

Efficacy of Omadacycline Versus Moxifloxacin in the Treatment of Community-Acquired Bacterial Pneumonia by Disease Severity: Results From the OPTIC Study

Open forum infectious diseases, 2021-06, Vol.8 (6), p.ofab135-ofab135

2021

Volltextzugriff (PDF)

Clinical Efficacy of Patients With Secondary Bacteremia Treated With Omadacycline: Results From Phase 3 Acute Bacterial Skin and Skin Structure Infections and Community-Acquired Bacterial Pneumonia Studies

Open forum infectious diseases, 2021-06, Vol.8 (6), p.ofab136-ofab136

2021

Volltextzugriff (PDF)

Patient-Level Data Provide Additional Insight for Tigecycline All-Cause Mortality Meta-analysis

Clinical infectious diseases, 2012-12, Vol.55 (12), p.1739-1740

2012

Volltextzugriff (PDF)

Methicillin-resistant Staphylococcus aureus infection epidemiology and clinical response from tigecycline soft tissue infection trials

Diagnostic microbiology and infectious disease, 2014-06, Vol.79 (2), p.261-265

2014

Volltextzugriff (PDF)

Long-term immune responses to pneumococcal conjugate vaccines in children previously vaccinated with 7-valent pneumococcal conjugate vaccine

The Pediatric infectious disease journal, 2013-09, Vol.32 (9), p.990-997

2013

Volltextzugriff (PDF)

Efficacy of tigecycline versus ceftriaxone plus metronidazole for the treatment of complicated intra-abdominal infections: results from a randomized, controlled trial

Surgical infections, 2012-04, Vol.13 (2), p.102-109

2012

Volltextzugriff (PDF)

1 – 25 von 203

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(189)
Mit Volltextzugriff
(168)

Publikationsform

Sprache

Englisch
(201)
Französisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(149)
Life Sciences & Biomedicine
(138)
Humans
(123)
Female
(78)
Male
(71)
Middle Aged
(53)
Adult
(47)
Biological And Medical Sciences
(45)
Medical Sciences
(43)
Aged
(39)
Infectious Diseases
(31)
Microbiology
(23)
Public, Environmental & Occupational Health
(20)
General & Internal Medicine
(19)
Immunology
(19)
Medicine, General & Internal
(18)
Risk Factors
(17)
Treatment Outcome
(17)
Adolescent
(14)
Tumors
(14)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Randomized Phase 2 Trial To Evaluate the Clinical Efficacy of Two High-Dosage Tigecycline Regimens versus Imipenem-Cilastatin for Treatment of Hospital-Acquired Pneumonia

Omadacycline vs moxifloxacin in adults with community-acquired bacterial pneumonia

Omadacycline for Community-Acquired Bacterial Pneumonia

Clinical response and mortality in tigecycline complicated intra-abdominal infection and complicated skin and soft-tissue infection trials

Once-daily oral omadacycline versus twice-daily oral linezolid for acute bacterial skin and skin structure infections (OASIS-2): a phase 3, double-blind, multicentre, randomised, controlled, non-inferiority trial

Cefepime–Taniborbactam in Complicated Urinary Tract Infection

Safety and efficacy of omadacycline by BMI categories and diabetes history in two Phase III randomized studies of patients with acute bacterial skin and skin structure infections

An Integrated Safety Summary of Omadacycline, a Novel Aminomethylcycline Antibiotic

Tigecycline Does Not Prolong Corrected QT Intervals in Healthy Subjects

Omadacycline for Acute Bacterial Skin and Skin Structure Infections

Patient outcomes by baseline pathogen resistance phenotype and genotype in CERTAIN-1, a Phase 3 study of cefepime-taniborbactam versus meropenem in adults with complicated urinary tract infection

All-cause mortality imbalance in the tigecycline phase 3 and 4 clinical trials

Early Clinical Response in Community-acquired Bacterial Pneumonia: From Clinical Endpoint to Clinical Practice

Distribution of 13-Valent Pneumococcal Conjugate Vaccine Streptococcus pneumoniae Serotypes in US Adults Aged ≥50 Years With Community-Acquired Pneumonia

The Effect of Verapamil, a P-gp Inhibitor, on the Pharmacokinetics, Safety, and Tolerability of Omadacycline in Healthy Adults: A Phase I, Open-Label, Single-Sequence Study

Efficacy and Safety of Omadacycline Versus Linezolid in Acute Bacterial Skin and Skin Structure Infections in Persons Who Inject Drugs

Safety and efficacy of omadacycline for treatment of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections in patients with mild-to-moderate renal impairment

Endemic babesiosis in another eastern state: New Jersey

Pancreatitis in tigecycline Phase 3 and 4 clinical studies

Efficacy of Omadacycline Versus Moxifloxacin in the Treatment of Community-Acquired Bacterial Pneumonia by Disease Severity: Results From the OPTIC Study

Clinical Efficacy of Patients With Secondary Bacteremia Treated With Omadacycline: Results From Phase 3 Acute Bacterial Skin and Skin Structure Infections and Community-Acquired Bacterial Pneumonia Studies

Patient-Level Data Provide Additional Insight for Tigecycline All-Cause Mortality Meta-analysis

Methicillin-resistant Staphylococcus aureus infection epidemiology and clinical response from tigecycline soft tissue infection trials

Long-term immune responses to pneumococcal conjugate vaccines in children previously vaccinated with 7-valent pneumococcal conjugate vaccine

Efficacy of tigecycline versus ceftriaxone plus metronidazole for the treatment of complicated intra-abdominal infections: results from a randomized, controlled trial

Suchergebnisse filtern